IDEA-FAST consortium receives € 44 Mio. from EU IMI2/Horizon 2020 program - GHI partner

The IMI2 consortium IDEA-FAST receives € 44 Mio. funding in the Horizon 2020 programm of the European Union to support the development of sensorbased technologies to assess the severity of global functional deficits of patients with different diseases including Huntington's disease in everyday settings. GHI is responsible to conduct the feasibility study in HD and to coordinate the validation study across several European HD centers.